Ligand to Participate in H.C. Wainwright 20th Annual Global Investment Conference
Ligand Makes Offer to Acquire Vernalis, a Leader in Structure-Based Drug Discovery, For Approximately $43 Million in Cash
Ligand Reports Second Quarter 2018 Financial Results
Ligand to Report Second Quarter 2018 Results on August 6th
Ligand Receives $47 Million from WuXi Biologics for Expansion of Worldwide OmniAb® Platform License Agreement
Ligand Prices Offering of $650 Million of Convertible Senior Notes
Ligand Announces Proposed Offering of $650 Million of Convertible Senior Notes
Ligand to Participate in Upcoming Investor Conferences
Ligand Reports First Quarter 2018 Financial Results
